within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07E_IntestinalAntiinflammatoryAgents.A07EC04_Balsalazide;

model Balsalazide
  extends Pharmacolibrary.Drugs.ATC.A.A07EC04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A07EC04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Balsalazide is an anti-inflammatory drug belonging to the class of aminosalicylates, used primarily in the treatment of mild-to-moderate ulcerative colitis. It is a prodrug that releases mesalazine (5-aminosalicylic acid, 5-ASA) in the colon. Balsalazide is approved for use in the United States and certain other regions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Sandborn, WJ, et al., &amp; Buch, A (2004). Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers. <i>Alimentary pharmacology &amp; therapeutics</i> 19(10) 1089–1098. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2036.2004.01964.x&quot;>10.1111/j.1365-2036.2004.01964.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15142198/&quot;>https://pubmed.ncbi.nlm.nih.gov/15142198</a></p></li><li><p>Muijsers, RB, &amp; Goa, KL (2002). Balsalazide: a review of its therapeutic use in mild-to-moderate ulcerative colitis. <i>Drugs</i> 62(11) 1689–1705. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200262110-00010&quot;>10.2165/00003495-200262110-00010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12109930/&quot;>https://pubmed.ncbi.nlm.nih.gov/12109930</a></p></li><li><p>Tursi, A (2009). Balsalazide in treating colonic diseases. <i>Expert opinion on drug metabolism &amp; toxicology</i> 5(12) 1555–1563. DOI:<a href=&quot;https://doi.org/10.1517/17425250903228842&quot;>10.1517/17425250903228842</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19708827/&quot;>https://pubmed.ncbi.nlm.nih.gov/19708827</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Balsalazide;
